The Montreal Heart Institute (MHI) is proud to announce that Claudie Roussy and Émilie Caplette are the recipients of the second annual Dr. Denis Roy Award for Excellence. Each year, this prestigious award honours MHI nursing staff members who distinguish themselves in their work.
The Montreal Heart Institute (MHI) is proud to announce that Dr. Jean-Claude Tardif has been honoured with the 2021 Margolese National Heart Disorders Prize. This prestigious distinction is awarded annually to a Canadian physician or scientist who makes outstanding contributions to heart disorders’ treatment, amelioration, or cure.
Opening the fundraising season, the Grand Bal des Vins-Cœurs was held virtually on Thursday, September 9, with generous philanthropists from the Montreal business community. The 21st edition of the Montreal Heart Institute Foundation’s signature event raised $1,002,040 for cardiovascular health.
People with coronary disease now have a new treatment option to reduce the risk of cardiovascular events. Health Canada has issued a Notice of Compliance for the prescription drug MYINFLA™ (colchicine 0.5 mg tablets) based on the results of the Montreal Heart Institute (MHI)’s COLCOT clinical trial.
The 35th edition of the Kanawaki Golf Tournament was held on August 2. This gathering, the Foundation’s first in over a year, was a great success. The Foundation is proud to announce that a total of $123,000 was raised thanks to this event, the highest amount in at least 10 years!
The Grand Bal des Vins-Cœurs, the Montreal Heart Institute Foundation’s flagship event, will be taking place virtually on September 9th. The co-presidents of the Grand Bal – Ms. France Chrétien Desmarais, Mr. Anthony M. Fata, Mr. Mitch Garber, and Mr. Tony Meti – invite you to join the festivities which also mark the arrival of fall in our beautiful city.
The Montreal Heart Institute announces that the surgery department has implanted a new biological aortic prosthesis in a patient, a Canadian first. This cutting-edge medical device reduces the time required for surgery and the risk of complications; thus, patients enjoy a better quality of life.
The Montreal Heart Institute is proud to announce that the interventional cardiology team has implanted new drug-eluting stents (DES) in two patients: one a Canadian first, the other a North American first. These medical devices, among the most effective in cardiology, help reduce the risk of complications and death in people with coronary artery disease.